RecruitingNCT02744365

Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications

Biobank of Data and of Human Biological Samples on Prematurity, Preeclampsia and Other Pregnancy Complications


Sponsor

CHU de Quebec-Universite Laval

Enrollment

7,845 participants

Start Date

Apr 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

The Biobank includes data and biological specimens of women from three original studies: 1) First-trimester Prediction of Preeclampsia (PREDICTION Study, NCT02189148), 2) Pre-Eclampsia And growth Retardation, an evaluative Longitudinal study (PEARL Study, NCT02379832), 3) Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial (NCT02280031) and 4)PREDICTION2: Prediction of Preeclampsia and other Pregnancy Complications Following Combined Iterative Screening.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting biological samples (such as blood and tissue) from pregnant women who experience complications like premature birth, preeclampsia (dangerously high blood pressure in pregnancy), or other serious pregnancy problems, to help researchers understand what causes these conditions. **You may be eligible if...** - You are a pregnant woman experiencing or at risk for complications such as premature labor, preeclampsia, or other serious pregnancy issues - You are 18 years or older - Your baby has a heartbeat at the time of enrollment - Specific eligibility depends on the sub-study you are being enrolled in **You may NOT be eligible if...** - You are under 18 years old - Your baby no longer has a heartbeat at the time of enrollment - You are not able to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservational

All women of the biobank have provided: 1. blood samples (plasma, serum and Buffy-coat) 2. urine samples 3. demographic and clinical data (maternal age, BMI, smoking status, obstetrical and medical history) 4. mean arterial blood pressure 5. ultrasound examination (datation of pregnancy at recruitment, uterine arteries doppler, placental volume, nuchal translucency in the majority of the cases) 6. access to medical record (for pregnancy/delivery outcomes, newborn birthweight, gestational age at delivery)


Locations(1)

CHU de Quebec

Québec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02744365


Related Trials